Analysts expect Marker Therapeutics, Inc. to report revenue of 2.19 M for Q3 26, against a range of 2.06 M to 2.32 M. The most recent reported quarter, Q2 26, came in at 700,000.00, a 11.7% beat against the 626,893.25 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 1.93 M | 2.25 M | 349,100.00 | 880,600.00 | 1.23 M | 1.10 M | 800,000.00 | 700,000.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 992,666.73 | 1.34 M | 199,392.04 | 423,967.49 | 720,474.23 | 711,239.14 | 789,877.60 | 650,540.29 | 2.32 M | 757,232.36 | 1.36 M | 1.26 M | 6.01 M | 3.53 M | 10.46 M | 11.65 M | ||||||||||
| Low Estimate | 906,523.27 | 1.18 M | 171,561.62 | 378,072.37 | 624,862.49 | 602,055.74 | 709,793.66 | 603,246.21 | 2.06 M | 637,167.56 | 1.18 M | 1.05 M | 5.45 M | 3.21 M | 8.59 M | 10.01 M | ||||||||||
| Consensus Estimate | 949,595.00 | 1.26 M | 185,476.83 | 401,019.93 | 672,668.36 | 656,647.44 | 749,835.63 | 626,893.25 | 2.19 M | 697,199.96 | 1.27 M | 1.16 M | 5.73 M | 3.37 M | 9.52 M | 10.83 M |
Analysts expect Marker Therapeutics, Inc. to report earnings per share of -0.13 for Q3 26, against a range of -0.14 to -0.12. The most recent reported quarter, Q2 26, came in at -0.09, a 30.8% beat against the -0.13 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.26 | -0.41 | -0.40 | -0.25 | -0.12 | -0.10 | -0.16 | -0.09 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.39 | -0.23 | -0.48 | -0.30 | -0.35 | -0.18 | -0.16 | -0.12 | -0.12 | -0.20 | -0.20 | -0.23 | -0.15 | -0.21 | 0.06 | 0.12 | ||||||||||
| Low Estimate | -0.43 | -0.25 | -0.54 | -0.34 | -0.41 | -0.22 | -0.18 | -0.14 | -0.14 | -0.22 | -0.22 | -0.25 | -0.17 | -0.25 | 0.06 | 0.12 | ||||||||||
| Consensus Estimate | -0.41 | -0.24 | -0.51 | -0.32 | -0.38 | -0.20 | -0.17 | -0.13 | -0.13 | -0.21 | -0.21 | -0.24 | -0.16 | -0.23 | 0.06 | 0.12 |
Pull Wall Street consensus for Marker Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=MRKR&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "MRKR", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=MRKR&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();